About 110 results

ALLMedicine™ 5q- Syndrome Center

Research & Reviews  42 results

p53 activation during ribosome biogenesis regulates normal erythroid differentiation.
Blood Le Goff S, Boussaid I et. al.

Aug 21st, 2020 - The role of ribosome biogenesis in erythroid development is supported by the recognition of erythroid defects in ribosomopathies in both Diamond-Blackfan anemia and 5q- syndrome. Whether ribosome biogenesis exerts a regulatory function on normal e...

Integrated analyses of translatome and proteome identify the rules of translation selec...
Haematologica Boussaid I, Le Goff S et. al.

Apr 25th, 2020 - In ribosomopathies, the Diamond-Blackfan anemia (DBA) or 5q- syndrome, ribosomal protein (RP) genes are affected by mutation or deletion, resulting in bone marrow erythroid hypoplasia. Unbalanced production of ribosomal subunits leading to a limit...

Pediatric Myelodysplastic Syndromes (MDS) Pathology 

Dec 17th, 2019 - Myelodysplastic syndrome (MDS) is a set of disorders characterized by marrow failure with peripheral blood cytopenias, a peculiar set of morphologic abnormalities in hematopoietic cells, increased marrow blasts in some cases, frequent characterist...

Loss of rps9 in Zebrafish Leads to p53-Dependent Anemia.
G3 (Bethesda, Md.); Chen C, Huang H et. al.

Oct 18th, 2019 - Ribosome is a vital molecular machine for protein translation in the cell. Defects in several ribosomal proteins including RPS19, RPL11 and RPS14 have been observed in two types of anemia: Diamond Blackfan Anemia and 5q- syndrome. In zebrafish, de...

Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype an...
Leukemia Ribezzo F, Snoeren IAM et. al.

Jan 18th, 2019 - RPS14, CSNK1A1, and miR-145 are universally co-deleted in the 5q- syndrome, but mouse models of each gene deficiency recapitulate only a subset of the composite clinical features. We analyzed the combinatorial effect of haploinsufficiency for Rps1...

see more →

Clinicaltrials.gov  1 results

Leucovorin for the Treatment of 5 q Minus Syndrome

Mar 4th, 2008 - The objective of this protocol is to determine whether leucovorin treatment can normalize hematopoietic cell growth and differentiation in patients with 5q- syndrome which may lack the gene for dihydrofolate reductase enzyme.

see more →

News  1 results

Case Presentation: Myelodysplastic Syndromes

Dec 5th, 2020 - Normal Blood Cell Development Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow. In patients with MDS, the blood stem cells fail to mature into functioning red blood c...

see more →